TestCard, a London, UK-based healthtech company providing an urine test solution, completed a $1.7m in seed financing.
The round was led by Neo Ventures.
The company intends to use the funds to launch and initial roll out phase.
Led by Dr. Andrew Botham (co-founder and CSO), Luke Heron (CEO and co-founder), and George Sutherland (Chairman), TestCard is to launch an at-home urine test solution, providing consumers and patients with accurate results at home.
The company’s service is a combination of a non-invasive urine test kit embedded into a postcard, with an accompanying mobile application that turns a phone’s camera into a clinical grade scanner.
The applications vary from detection of urinary tract infections (UTIs) through to pregnancy testing that will provide a specific due date for positive tests, whilst providing an optimal date to try and conceive for tests that show up negative.
The product pipeline includes other analysis test products such as prostate health screening alongside the monitoring of health conditions like diabetes and kidney disease.